Loading clinical trials...
Loading clinical trials...
Cetrorelix Pamoate (AEZS-102) in Patients With Symptomatic BPH: an Open-Labeled Safety and Efficacy Assessment Study
Conditions
Interventions
Cetrorelix Pamoate
Locations
69
United States
Urology Centers of Alabama
Homewood, Alabama, United States
Medical Affiliated Research Center, Inc.
Huntsville, Alabama, United States
South Orange County Medical Research Center
Laguna Hills, California, United States
California Professionnal Research
Newport Beach, California, United States
Northern California Research
Sacramento, California, United States
San Diego Uro Research
San Diego, California, United States
Start Date
March 1, 2008
Primary Completion Date
August 1, 2009
Completion Date
August 1, 2009
Last Updated
April 5, 2011
NCT07377929
NCT00427219
NCT02401581
NCT00382356
NCT00663858
Lead Sponsor
AEterna Zentaris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions